Langeggen H, Berge K E, Macor P, Fischetti F, Tedesco F, Hetland G, Berg K, Johnson E
Department of Gastroenterological Surgery, Ullevål University Hospital, Oslo, Norway.
APMIS. 2001 Jan;109(1):73-8. doi: 10.1111/j.1600-0463.2001.tb00016.x.
Human umbilical vein endothelial cells (HUVEC) have previously been shown to synthesize the functional terminal pathway of complement based on the detection by radioimmunoassay of the terminal complement complex (TCC) on coincubated agarose beads. In addition, C7 secretion by these cells in amounts comparable to C3, as well as C7 mRNA, has recently been demonstrated. However, it has not been possible to detect C5-6 and C8 in the fluid phase, and only trace amounts of soluble C9. Against this background we examined whether mRNA for the remaining terminal complement factors was present in HUVEC. By the use of reverse transcription (RT)-polymerase chain reaction (PCR) and Northern blot the presence of mRNA for complement factors C5, C6, C8 and C9 was demonstrated.
先前已表明,通过放射免疫分析法检测共孵育琼脂糖珠上的末端补体复合物(TCC),人脐静脉内皮细胞(HUVEC)能够合成补体的功能性终末途径。此外,最近已证实这些细胞分泌的C7量与C3相当,并且还存在C7 mRNA。然而,尚未在液相中检测到C5-6和C8,仅检测到痕量的可溶性C9。在此背景下,我们研究了HUVEC中是否存在其余末端补体因子的mRNA。通过逆转录(RT)-聚合酶链反应(PCR)和Northern印迹法,证实了补体因子C5、C6、C8和C9的mRNA的存在。